Onconetix, Inc. (ONCO)
1.03
+0.12
(+13.07%)
USD |
NASDAQ |
Sep 25, 16:00
1.14
+0.11
(+10.68%)
After-Hours: 17:17
Onconetix Cash from Operations (TTM) : -10.31M for June 30, 2026
Cash from Operations (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Cash from Operations (TTM) Data
| Date | Value |
|---|---|
| June 30, 2026 | -10.31M |
| March 31, 2026 | -9.800M |
| December 31, 2025 | -9.678M |
| September 30, 2025 | -7.906M |
| June 30, 2025 | -5.874M |
| March 31, 2025 | -7.663M |
| December 31, 2024 | -10.90M |
| September 30, 2024 | -13.89M |
| Date | Value |
|---|---|
| June 30, 2024 | -15.78M |
| March 31, 2024 | -14.37M |
| December 31, 2023 | -13.58M |
| September 30, 2023 | -12.07M |
| June 30, 2023 | -10.86M |
| March 31, 2023 | -12.26M |
| December 31, 2022 | -8.699M |
| September 30, 2022 | -6.572M |
Cash From Operations Definition
Represents the net cash flow from the company's business operations.
Cash from Operations (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Operations (TTM) Benchmarks
| BridgeBio Pharma, Inc. | -434.37M |
| Aprea Therapeutics, Inc. | -12.30M |
| ACADIA Pharmaceuticals, Inc. | 160.32M |
| Alnylam Pharmaceuticals, Inc. | 885.89M |
| Anika Therapeutics, Inc. | 5.977M |